In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions

Veterinary Microbiology

Volumn 155, Issue 2-4, 2012, Pages 395-398

  Cafarchia, Claudia ^a   Figueredo, Luciana A ^a   Iatta, Roberta ^a   Montagna, Maria Teresa ^a   Otranto, Domenico ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Antifungal susceptibility; CLSI reference broth microdilution method; Dog; Malassezia pachydermatis

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; POSACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOG DISEASE; FUNGAL STRAIN; IN VITRO STUDY; MALASSEZIA PACHYDERMATIS; MALASSEZIA PACHYDERMATIS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

ANIMALS; ANTIFUNGAL AGENTS; DERMATOMYCOSES; DOG DISEASES; DOGS; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; MALASSEZIA; MICONAZOLE; NAPHTHALENES; PYRIMIDINES; TRIAZOLES;

CANIS FAMILIARIS; MALASSEZIA; MALASSEZIA PACHYDERMATIS;

EID: 84857039914     PISSN: 03781135     EISSN: 18732542     Source Type: Journal    
DOI: 10.1016/j.vetmic.2011.09.008     Document Type: Article

References (22)

1. Bond R. Superficial veterinary mycoses. Clin. Dermatol. 2010, 28:226-236.
2. Cafarchia C., Dell'Aquila M.E., Traversa D., Albrizio M., Guaricci A.C., de Santis T., Otranto D. Expression of the micro-opioid receptor on Malassezia pachydermatis and its effect in modulating phospholipase production. Med. Mycol. 2009, 18:1-6.
3. Cantón E., Espinel-Ingroff A., Pemán J. Trends in antifungal susceptibility testing using CLSI reference and commercial methods. Expert Rev. Anti Infect. Ther. 2009, 7:107-119.
4. Chen T.A., Hill P.B. The biology of Malassezia organisms and their ability to induce immune responses and skin disease. Vet. Dermatol. 2005, 16:4-26.
5. Eichenberg M., Appelt C.E., Berg V., Muschner A., Nobre M., Mata D., Alves S., Ferreiro L. Suscetibility of Malassezia pachydermatis to azole antifungal agent evaluate by a new broth microdilution method. Acta Sci. Vet. 2003, 31:75-80.
6. Garau M., Pereiro M., del Palacio A. In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds. Antimicrob. Agents Chemother. 2003, 47:2342-2344.
7. Guillot J., Guého E., Lesourd M., Midgley G., Chevrier G., Dupont B. Identification of Malassezia species. A practical approach. J. Mycol. Med. 1996, 6:103-111.
8. Gupta A.K., Kohli Y., Li A., Faergemann J., Summerbell R.C. In vitro susceptibility of the seven Malassezia species to ketoconazole, voriconazole, itraconazole and terbinafine. Br. J. Dermatol. 2000, 142:758-765.
9. Hitchcock C.A., Barrett-Bee K.J., Russell N.J. The lipid composition and permeability to the triazole antifungal antibiotic ICI 153066 of serum-grown mycelial cultures of Candida albicans. J. Gen. Microbiol. 1989, 135:1949-1955.
10. Jesus, F.P., Lautert, C., Zanette, R.A., Mahl, D.L., Azevedo, M.I., Machado, M.L., Dutra, V., Botton, S.A., Alves, S.H., Santurio, J.M., 2011. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles. Vet. Microbiol. 152, 161-164.
11. Nascente P.S., Meinerz A.R.M., Faria R.O., Schuch L.F.D., Meireles D.C.A., Mello J.R.B. CLSI broth microdilution method for testing susceptibility of Malassezia pachydermatis to thiabendazole. Braz. J. Microbiol. 2009, 40:222-226.
12. Nascente P.S., Nobre M.O., Schuch L.F., Lucia-Junior T., Ferreiro L., Meireles M.C.A. Evaluation of Malassezia pachydermatis antifungal susceptibility using two different methods. Braz. J. Microbiol. 2003, 34:359-362.
13. National Committee for Clinical Laboratory Standards Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, M27-A2 2002, NCCLS, Villanova, PA, USA. 2nd ed.
14. Nijima M., Kano R., Nagata M., Hasegawa A., Kamata H. An azole-resistant isolate of Malassezia pachydermatis. Vet. Microbiol. 2011, 149:288-290.
15. Pfaller M.A., Diekema D.J. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 2007, 20:133-163.
16. Prado M.R., Brito E.H., Brilhante R.S., Cordeiro R.A., Leite J.J., Sidrim J.J., Rocha M.F. Subculture on potato dextrose agar as a complement to the broth microdilution assay for Malassezia pachydermatis. J. Microbiol. Methods 2008, 75:341-343.
17. Pietschmann S., Hoffmann K., Voget M., Pison U. Synergistic effects of miconazole and polymyxin B on microbial pathogens. Vet. Res. Commun. 2009, 33:489-505.
18. Rex J.H., Pfaller M.A., Galgiani J.N., Bartlett M.S., Espinel-Ingroff A., Ghannoum M.A., Lancaster M., Odds F.C., Rinaldi M.G., Walsh T.J., Barry A.L. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. Clin. Infect. Dis. 1997, 24:235-247.
19. Rincón S., Garcia M.C.C., Espinel-Ingroff A. A modified christensen's urea and CLSI broth microdilution method for testing susceptibilities of six Malassezia species to voriconazole, itraconazole, and ketoconazole. J. Clin. Microbiol. 2006, 44:3429-3431.
20. Sugita T., Tajima M., Ito T., Saito M., Tsuboi R., Nishikawa A. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J. Clin. Microbiol. 2005, 43:2824-2829.
21. Velegraki A., Alexopoulos E.C., Kritikou S., Gaitanis G. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest. J. Clin. Microbiol. 2004, 242:3589-3593.
22. Vermitsky J.P., Edlind T.D. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor. Antimicrob. Agents Chemother. 2004, 48:3773-3781.